KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Consolidated Net Income (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Consolidated Net Income for 16 consecutive years, with $1.8 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Consolidated Net Income rose 11.45% year-over-year to $1.8 billion, compared with a TTM value of $6.4 billion through Dec 2024, up 6.07%, and an annual FY2025 reading of $6.8 billion, up 5.97% over the prior year.
  • Consolidated Net Income was $1.8 billion for Q4 2024 at Thermo Fisher Scientific, up from $1.6 billion in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $2.5 billion in Q4 2020 and bottomed at $788.0 million in Q1 2020.
  • Average Consolidated Net Income over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2021.
  • The sharpest move saw Consolidated Net Income skyrocketed 196.57% in 2021, then tumbled 41.18% in 2023.
  • Year by year, Consolidated Net Income stood at $2.5 billion in 2020, then plummeted by 33.72% to $1.7 billion in 2021, then fell by 3.32% to $1.6 billion in 2022, then rose by 0.19% to $1.6 billion in 2023, then rose by 11.45% to $1.8 billion in 2024.
  • Business Quant data shows Consolidated Net Income for TMO at $1.8 billion in Q4 2024, $1.6 billion in Q3 2024, and $1.6 billion in Q2 2024.